Canopy Growth (CGC) Return on Sales (2019 - 2026)
Canopy Growth (CGC) posted Return on Sales of 0.0% for Q4 2025, up 84.22% sequentially from 0.0% in Q3 2025, and little changed YoY from 0.0% in Q4 2024.
Canopy Growth (CGC) Return on Sales (2019 - 2026) Analysis & Trends
Canopy Growth has reported Return on Sales for 7 years, with the latest figure at 0.0% in Q4 2025.
- Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
- Return on Sales grew to 0.0% in Q4 2025 per CGC's latest filing, from 0.0% in the prior quarter.
- Over five years, Return on Sales peaked at 0.03% in Q2 2021 and troughed at 0.18% in Q2 2022.
- A 5-year average of 0.01% and a median of 0.0% in 2025 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2021 and 2022: Return on Sales jumped 47 bps in 2021, then declined 20 bps in 2022.
- Over 5 years, Return on Sales stood at 0.01% in 2021, then soared by 41 bps to 0.0% in 2022, then surged by 139 bps to 0.0% in 2023, then tumbled by 84 bps to 0.0% in 2024, then plunged by 142 bps to 0.0% in 2025.
- According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Canopy Growth | 441.27 Mn | 194.25 Mn | 16.08 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.03% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.18% |
| Mar 31, 2022 | 0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.03% |
| Mar 31, 2021 | -0.01% |